These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10664280)

  • 1. Recent status of primary sclerosing cholangitis in Japan.
    Takikawa H
    J Hepatobiliary Pancreat Surg; 1999; 6(4):352-5. PubMed ID: 10664280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary sclerosing cholangitis in Japan--analysis of 192 cases.
    Takikawa H; Manabe T
    J Gastroenterol; 1997 Feb; 32(1):134-7. PubMed ID: 9058310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary sclerosing cholangitis in Japanese patients: association with inflammatory bowel disease.
    Okada H; Mizuno M; Yamamoto K; Tsuji T
    Acta Med Okayama; 1996 Oct; 50(5):227-35. PubMed ID: 8914675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary tract calculi in primary sclerosing cholangitis.
    Kaw M; Silverman WB; Rabinovitz M; Schade RR
    Am J Gastroenterol; 1995 Jan; 90(1):72-5. PubMed ID: 7801953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geoepidemiology of primary sclerosing cholangitis: a critical review.
    Tanaka A; Takikawa H
    J Autoimmun; 2013 Oct; 46():35-40. PubMed ID: 23932346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan.
    Tanaka A; Tazuma S; Okazaki K; Tsubouchi H; Inui K; Takikawa H
    J Hepatobiliary Pancreat Sci; 2014 Jan; 21(1):43-50. PubMed ID: 24353071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis.
    Sano H; Nakazawa T; Ando T; Hayashi K; Naitoh I; Okumura F; Miyabe K; Yoshida M; Takahashi S; Ohara H; Joh T
    J Hepatobiliary Pancreat Sci; 2011 Mar; 18(2):154-61. PubMed ID: 20740366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
    Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
    Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort.
    Liu K; Wang R; Kariyawasam V; Wells M; Strasser SI; McCaughan G; Corte C; Leong RW
    Liver Int; 2017 Mar; 37(3):442-448. PubMed ID: 27891750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2016 diagnostic criteria for primary sclerosing cholangitis.
    Nakazawa T; Notohara K; Tazuma S; Tanaka A; Isayama H; Tsuyuguchi T; Mori T; Takikawa H
    J Gastroenterol; 2017 Jul; 52(7):838-844. PubMed ID: 27921168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
    de Vries AB; Janse M; Blokzijl H; Weersma RK
    World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-mediated diseases in primary sclerosing cholangitis.
    Lamberts LE; Janse M; Haagsma EB; van den Berg AP; Weersma RK
    Dig Liver Dis; 2011 Oct; 43(10):802-6. PubMed ID: 21700515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis.
    Ngu JH; Gearry RB; Wright AJ; Stedman CA
    Clin Gastroenterol Hepatol; 2011 Dec; 9(12):1092-7; quiz e135. PubMed ID: 21893134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis.
    Nakazawa T; Ohara H; Sano H; Ando T; Aoki S; Kobayashi S; Okamoto T; Nomura T; Joh T; Itoh M
    Pancreas; 2005 Jan; 30(1):20-5. PubMed ID: 15632695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of primary sclerosing cholangitis in israel is independent of coexisting inflammatory bowel Disease.
    Yanai H; Matalon S; Rosenblatt A; Awadie H; Berdichevski T; Snir Y; Kopylov U; Katz L; Stein A; Mlynarsky L; Tulchinsky H; Konikoff FM; Horin SB; Braun M; Ben-Ari Z; Chowers Y; Baruch Y; Shibolet O; Dotan I
    J Crohns Colitis; 2015 Feb; 9(2):177-84. PubMed ID: 25518055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
    Broomé U; Bergquist A
    Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI.
    Kim JH; Byun JH; Kim SY; Lee SS; Kim HJ; Kim MH; Lee MG
    Acta Radiol; 2013 Jul; 54(6):601-7. PubMed ID: 23528564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of IgG-4-associated cholangiopathy based on serum IgG-4 levels in patients with primary sclerosing cholangitis and its relationship with inflammatory bowel disease.
    Taghavi SA; Majd SK; Sianati M; Sepehrimanesh M
    Turk J Gastroenterol; 2016 Nov; 27(6):547-552. PubMed ID: 27852547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG4-negative autoimmune pancreatitis with sclerosing cholangitis and colitis: possible association with primary sclerosing cholangitis?
    Saeki K; Hozawa S; Miyata N; Nishizawa T; Soma H; Iwao Y; Kameyama K; Hibi T
    Intern Med; 2008; 47(10):943-8. PubMed ID: 18480579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP-2 is a disease-modifying gene in primary sclerosing cholangitis.
    Korkmaz KS; de Rooij BJ; van Hoek B; Janse M; Coenraad MJ; van der Reijden JJ; Weersma RK; Porte RJ; Voorneveld PW; Baranski AG; Verspaget HW
    Liver Int; 2014 Feb; 34(2):274-80. PubMed ID: 23809662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.